Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Amgen
Amgen
Biopharma buyouts bounce back
EP Vantage
Wed, 07/5/23 - 10:17 am
M&A
Amgen
Astellas
Eli Lilly
GSK
Horizon Therapeutics
Merck
Novartis
Pfizer
Seagen
States Back FTC in Lawsuit Seeking to Block Amgen-Horizon Deal
BioSpace
Fri, 06/23/23 - 09:53 am
Amgen
Horizon Therapeutics
M&A
FTC
Amgen granted full FDA approval for blood cancer treatment
Biopharma Reporter
Thu, 06/22/23 - 10:10 am
Amgen
Blincyto
FDA
blood cancer
Full circle for Paul Burton as Moderna exec returns to Amgen, this time for expanded CMO role
Fierce Biotech
Wed, 06/14/23 - 06:33 pm
Amgen
Moderna Therapeutics
Paul Burton
chief medical officers
Medicare sets next tranche of drugs to face price hike penalties
BioPharma Dive
Sun, 06/11/23 - 11:02 pm
Medicare
Inflation Reduction Act
drug pricing
Amgen
Sanofi
Seagen
Study: Biosimilars ‘fulfilling their promise’ of lowering biologic prices
BioSpace
Wed, 06/7/23 - 11:22 am
biosimilars
biologics
drug pricing
Roche
Herceptin
Amgen
Kanjinti
Viatris
Ogivri
Pfizer
Trazimera
Teva Pharmaceutical
Herzuma
Organon
Ontruzant
FTC’s Challenge to Amgen-Horizon Merger Sparks Industry Attention
BioSpace
Wed, 06/7/23 - 11:15 am
Amgen
Horizon Therapeutics
FTC
M&A
Amgen's Horizon buyout delayed again, pushing closure possibly to December
Fierce Pharma
Mon, 06/5/23 - 10:21 am
Amgen
Horizon Therapeutics
FTC
M&A
Global obesity drugs sales could top $44bn in 2030, says Bloomberg Intelligence
Biopharma Reporter
Wed, 05/31/23 - 11:08 am
obesity
weight loss
Novo Nordisk
Eli Lilly
Pfizer
Amgen
FTC Wants to Block the Amgen-Horizon Deal: Is Pfizer's Acquisition of Seagen at Risk, Too?
Motley Fool
Wed, 05/24/23 - 11:18 am
FTC
M&A
Amgen
Horizon Therapeutics
Pfizer
Seagen
Bayer, Amgen looked at Iveric before agreeing to Astellas sale
Seeking Alpha
Tue, 05/23/23 - 06:20 pm
Astellas
Iveric Bio
Bayer
Amgen
M&A
Amgen settles patent lawsuit over biosimilar of J&J's big-selling Stelara
Yahoo/Reuters
Tue, 05/23/23 - 06:14 pm
JNJ
Amgen
patents
Stelara
biosimilars
legal
Horizon Therapeutics says Amgen deal could close earlier than planned if FTC fails to block it
CNBC
Thu, 05/18/23 - 08:42 pm
Horizon Therapeutics
M&A
Amgen
FTC
Supreme Court rules against Amgen bid to revive cholesterol drug patents
KFGO/Reuters
Thu, 05/18/23 - 11:24 am
Supreme Court
Amgen
Sanofi
Regeneron
patents
Repatha
legal
Few signs of gout pipeline flaring up
EP Vantage
Thu, 05/18/23 - 10:45 am
gout
Selecta Biosciences
Sobi
SEL-212
3SBio
Amgen
Arthrosi Therapeutics
Atom Bioscience
Dyve Biosciences
Hinova Pharmaceuticals
Horizon Therapeutics
InventisBio
Jiangsu Hengrui Pharmaceuticals
JW Group
LG Chem
Olatec Therapeutics
Shanton Bioscience
Regeneron CEO backs FTC’s attempt to block $28B Amgen-Horizon deal
Medical Marketing and Media
Wed, 05/17/23 - 10:48 pm
Amgen
Horizon Therapeutics
FTC
Regeneron
antitrust
M&A
Leonard Schleifer
Does FTC attempt to block Amgen's Horizon buy spell trouble for Pfizer-Seagen? Not necessarily, analysts say
Fierce Pharma
Wed, 05/17/23 - 11:29 am
FTC
M&A
Amgen
Horizon Therapeutics
Pfizer
Seagen
antitrust
Heightened US antitrust fears rattle biopharma
EP Vantage
Wed, 05/17/23 - 10:12 am
M&A
antitrust
Amgen
Astellas
Bellus Health
Globus Medical
GSK
Horizon Therapeutics
Merck
NuVasive
Pfizer
Prometheus Biosciences
Seagen
Amgen ‘Remains Committed’ to $27.8B Horizon Acquisition After FTC Challenge
BioSpace
Tue, 05/16/23 - 11:02 pm
Amgen
Horizon Therapeutics
M&A
FTC
FTC sues to block Amgen’s $27.8B deal for Horizon Therapeutics
Medical Marketing and Media
Tue, 05/16/23 - 12:17 pm
Amgen
Horizon Therapeutics
FTC
M&A
Pages
« first
‹ previous
…
3
4
5
6
7
8
9
10
11
…
next ›
last »